68 related articles for article (PubMed ID: 28043602)
1. Screening new tuberculosis patients in Mali for rifampicin resistance at 2months.
Diarra B; Cissé AB; Kodio O; Sanogo M; Baya B; Togo AC; Somboro A; Tolofoudié M; Degoga B; Keita ML; Diallo F; Nguiakam N; Coulibaly G; Bane S; Sarro YD; Doumbia S; Murphy RL; Diallo S; Dejong BC
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S42-S43. PubMed ID: 28043602
[TBL] [Abstract][Full Text] [Related]
2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
3. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia.
Karuniawati A; Burhan E; Koendhori EB; Sari D; Haryanto B; Nuryastuti T; Gayatri AAAY; Bahrun U; Kusumawati RL; Sugiyono RI; Susanto NH; Diana A; Kosasih H; Naysilla AM; Lokida D; Neal A; Siddiqui S; Lau CY; Karyana M
Front Med (Lausanne); 2022; 9():909198. PubMed ID: 36743681
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
5. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali.
Diarra B; Decroo T; Somboro A; Coulibaly G; Tolofoudie M; Kone M; Degoga B; Diallo F; Togo ACG; Sanogo M; Sarro YS; Cisse AB; Kodio O; Baya B; Kone A; Maiga M; Dao S; Maiga II; Murphy RL; Siddiqui S; Toloba Y; Konate B; Diakite M; Doumbia S; Van Deun A; Rigouts L; Diallo S; de Jong BC
Int J Tuberc Lung Dis; 2020 Aug; 24(8):763-769. PubMed ID: 32912379
[No Abstract] [Full Text] [Related]
7. Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis.
Umair M; Siddiqui SA; Farooq MA
Cureus; 2020 Nov; 12(11):e11383. PubMed ID: 33312784
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
Khalil KF; Butt T
J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
[TBL] [Abstract][Full Text] [Related]
10. Systematic screening for drug-resistant tuberculosis with Xpert(®) MTB/RIF in a referral hospital in Cambodia.
Lorent N; Kong C; Kim T; Sam S; Thai S; Colebunders R; Rigouts L; Lynen L
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1528-35. PubMed ID: 26614197
[TBL] [Abstract][Full Text] [Related]
11. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.
Atashi S; Izadi B; Jalilian S; Madani SH; Farahani A; Mohajeri P
New Microbes New Infect; 2017 Sep; 19():117-120. PubMed ID: 28794886
[TBL] [Abstract][Full Text] [Related]
13. Discordance between GeneXpert assay and conventional drug-susceptibility testing in detecting rifampicin-resistant tuberculosis: A perspective of the line probe assay.
Ali RM; Alsudani AA
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S193-S194. PubMed ID: 28043548
[TBL] [Abstract][Full Text] [Related]
14. Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda.
Ssengooba W; de Dieu Iragena J; Komakech K; Okello I; Nalunjogi J; Katagira W; Kimuli I; Adakun S; Joloba ML; Torrea G; Kirenga BJ
Open Forum Infect Dis; 2021 Jun; 8(6):ofab173. PubMed ID: 34189166
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.
Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E
S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057
[TBL] [Abstract][Full Text] [Related]
17. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries.
Ardizzoni E; Fajardo E; Saranchuk P; Casenghi M; Page AL; Varaine F; Kosack CS; Hepple P
PLoS One; 2015; 10(12):e0144656. PubMed ID: 26670929
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
Ciftçi IH; Aslan MH; Aşık G
Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
Diarra B; Kone M; Togo ACG; Sarro YDS; Cisse AB; Somboro A; Degoga B; Tolofoudie M; Kone B; Sanogo M; Baya B; Kodio O; Maiga M; Belson M; Orsega S; Krit M; Dao S; Maiga II; Murphy RL; Rigouts L; Doumbia S; Diallo S; de Jong BC
PLoS One; 2018; 13(12):e0208603. PubMed ID: 30540823
[TBL] [Abstract][Full Text] [Related]
20. Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.
Heidebrecht CL; Podewils LJ; Pym AS; Cohen T; Mthiyane T; Wilson D
Sci Rep; 2016 Jan; 6():19391. PubMed ID: 26786396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
